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Due to pandemic Covid-19, suddenly the vast population is drawn towards herbal 
drug treatment in India. In India, Ayurveda is practised to a greater extent as it does 
not have any side effects or other major effects. They are also added in many nutra-
ceutical products like Chyawanprash, honey, etc. There are a lot of medicinal floras 
sold in the market in the form of small twigs, pieces of roots, stems or leaves of which 
decoction is made and consumed. The consumers are unaware of the authenticity of 
these crude drugs that lead to the deterioration in their health owing to the consump-
tion of inferior quality of products or their substitute or the illicit bioadulterants 
which look like any other common plant part. The herbal drugs could also be in 
the form of tablet, powder, etc. which might be adulterated with look-alike plant 
products. Thus, a new branch of Forensic Science, i.e. Herbal Drugs Forensic which 
deals with identification of fake herbal product by various techniques which might 
be chemical or biological in nature has come up. In fact, the analytical methods for 
the testing of various bioconstituents need to be standardized and validated. Thus to 
prevent herbal drug fraud, it has become necessary to develop the methods for their 
detection through an emerging field of Forensic Science, i.e. Herbal Drugs Forensic.
Keywords: adulteration, authenticity, fraud, herbal drugs, herbal drugs forensic, 
identification, standardization
1. Introduction: Ayurveda - the science of healing
‘The great thing about Ayurveda is that its treatments always yield side benefits, 
not side effects.’—Shubhra Krishan
Ayurveda is an age old science that deals with the sacred knowledge of healing 
and longevity. The word Ayurveda is derived from two words that is ‘Ayuh’ which 
means ‘life’ and ‘veda’ which means ‘science or knowledge’. Thus, Ayurveda itself 
defines its meaning as the science or knowledge of life. Not only a science, but 
Ayurveda is a tradition that originated in India and is practised since then.
In other words, Ayurveda is not only taking herbal preparation and waiting for it 
to give results but encouraging all of us to be an active participant in the journey of 
healing. This process involves learning about our relationship with the nature and 
elements and their unique combinations they form known as doshas.
The practice of Ayurveda dates back to over five thousand years, during the 
Vedic period of ancient India [1]. The tradition was kept alive by the vaidyas and 
acharyas (those who practise Ayurveda) till India got independence in 1947. After 
independence, Ayurveda saw a resurge in India and emerged as a major healthcare 
system. Not only in India, but in different parts of the world like China, Europe, 
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Middle East, etc., Ayurveda has been practised since long as the alternative medi-
cine system was not in reach of major population [2].
Along with Ayurveda, practice of Yoga and eastern spiritualism flourished 
towards the western world in twentieth century.
1.1 The positive side of Ayurvedic medicine
The most important advantage associated with ayurvedic medicines is that it 
gives no side- effects even if it does not cause any good to health. This property of 
Ayurvedic medicines makes it most popular among all systems of medicine. The 
practice of Ayurveda is as easy for the new practitioners as it is for the age old [3]. It 
does not work on the symptoms of the disease rather works on the root cause to treat 
the ailment permanently. That is why the practice of Ayurveda requires patience.
1.2 Ayurveda and the current pandemic
Antibiotics resistance across the world is already a problem, especially if Covid-
19 deepens as a syndemic in populations with antibiotic resistance [4, 5]. To fight 
with such a situation, Indian Ayurvedic system of healing can play a vital role. Also, 
against such a syndemic, there should be something that can act synergistically. For 
such a synergy, a combination of drugs can prove in a most effective manner that 
can not only help in fighting against such a syndemic but can also play an efficient 
role in boosting the immunity and acting as a line of defense against any such future 
epidemic.
2. Forensic botany and herbal drugs forensics
The study of plants and their role in criminal investigations is referred as 
‘Forensic botany’ [6, 7].
Forensic Botany not only involves the examination of botanical evidences pres-
ent near the victim or at crime scene but also involves the detection of any unwanted 
material present in the herbal drugs. Though this part is untouched in forensic 
botany and is considered differently under Ayurveda but whenever and wherever 
any illegal, intentional or unintentional substitution or adulteration in trade of 
natural/authentic product comes, forensic science has always a crucial role to play.
A fundamental Ayurvedic philosophy is that ‘food is medicine and medicine is 
food’. According to an Ayurvedic proverb ‘When diet is wrong, medicine is of no 
use; when diet is correct, medicine is of no need’.
Food, the fundamental for the sustenance of life is not unblemished from 
various malfeasances owing to the adulteration and falsification of food commod-
ity. Not only food but the drugs also are no safer enough to be completely relied 
upon. The food and the herbal drugs (prepared from the medicinal flora having 
one or more bioactive constituents) market offer a huge income due to growing 
population, their needs, consumerism and marketism. The various food products 
and herbal drugs available in the market are carrying lot of adulterants and coun-
terfeits that are almost impossible for a common man to detect [8–14]. Herbal 
drugs forensic is a branch of forensics and a multidisciplinary science that not only 
answers the questions as to ‘what’ and ‘how much’ related to drug safety and quality 
issues but also investigates the sources, fate, implications and possibilities related 
to adulteration, falsification, counterfeiting and substitution in nutraceuticals (the 
drugs or herbal supplements consumed for extra nutrient intake that is not fulfilled 




3. Trade in herbal drugs
According to National Medicinal Plant Board (NMPB) Report, India’s domestic 
herbal industry (since India being a major exporter of herbal raw drugs) has around 
8610 licensed herbal units, thousands of cottage level unregulated herbal units and 
millions of folk healers and household level users of thousands of herbal raw drugs. 
Also, the trade web that channelizes various herbal raw drugs from the supply to the 
end users is very complex. Thus, to have a better understanding of the Market and 
trade of the sector, we need to focus on demand and supply chains of the medicinal 
plants. The demand and supply chain of medicinal plants in the country is itself 
very complex.
Presently, medicinal plants are marketed and traded through Mandis and other 
wholesale markets in India with numerous intermediaries in between. Trade is 
rather opaque and information on prices, arrivals and other trends are difficult for 
farmers/growers to access. NMPB has been initiating many steps in order to fill 
this gap.
Another major gap between the demand and supply has emerged due to the 
commercialization of the production of classical Ayurveda, Siddha and Unani 
(ASU) formulations that require large quantities of wild harvested, cultivated 
or imported herbal raw drugs. This has resulted into thriving trade in raw drugs. 
Because of this, knowledge about the annual consumption levels of the herbal 
raw drug, the trends in their usage and their trade value is important so that the 
resources can be managed to ensure sustainable supplies to the herbal drug indus-
try, folk users and growing global markets [15].
3.1 Demand and supply position of medicinal plants
India has very strong traditional health care practices that are represented by the 
classical systems of medicine like Ayurveda, Siddha, Unani, and Swa-rigpa. Besides 
these traditional heath care practices, there exists a very diverse area-specific and 
community-specific folk healthcare practices. Both the Indian classical system of 
medicine and the folk health care systems are highly dependent on the raw herbal 
drug material derived from a diverse species of medicinal plants, which is estimated 
to be about 6500 in number [16].
NMPB, during 2001–2002, commissioned a study through Centre for Research, 
Planning and Action (CERPA) to understand annual trade levels of selected 162 
medicinal plant species. The NMPB, then in 2006–2007 commissioned a national 
study that was carried out by Foundation for Revitalisation of Local Health 
Traditions (FRLHT) to assess demand and supply of medicinal plants in India 
which for the first time highlighted various drawbacks in the herbal drug sector and 
added more to the existing knowledge and understanding of the subject related to 
the diversity of raw drugs in trade, their botanical correlation, volume of annually 
trade drugs, their supply sources and others [16].
Figure 1 below shows various Industrial uses of Medicinal Plants [17]. Each of 
these groups can contain a wide range of products like herbal medicinal products, 
food supplements or dietary supplements, foodstuffs, Cosmetics, etc.
Countries where the highest uses of traditional medicines are practiced include [18]:
• United Arab Emirates (100%)
• China (100%)
• India (70%)
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• Pakistan (70%)
• African countries (70–80%)
A major percentage of raw drugs are used in making plant extracts. This is 
carried out either by the end product manufacturers or by extract companies. In 
addition to this, there is an exorbitant demand in developed countries for plant 
based products including health supplements, herbal health drinks, herbal cosmet-
ics and various other health and personal care products. The current worth of the 
global market for herbal products is estimated around US$60 billion per year with a 
growth rate of 7% [16].
In India, trade in medicinal plants accounts for a turnover of Rs. 2300 crores of 
ayurvedic and herbal products with a contribution of about Rs. 1200 crores of over-
the-counter products. Currently Covid-19 pandemic has opened door to explore 
more in the ayurvedic treasures. This would help in enabling rapid access of these 
herbal drugs into developed country markets as well as in Indian market [16].
There are major challenges in tapping the substantial potential for utilizing 
medicinal, aromatic and natural dyes plants (MADPs) nationally in India, as well 
as in export markets. At the forefront of these problems is ensuring consistent and 
acceptable quality which always suffers against making money out of it. As this 
tradition has now moved to industries which was earlier a part of a local com-
munity’s culture and health practices, quality is not manageable and has suffered a 
Figure 1. 




lot. In case of medicinal plants, quality means the correct identity of the medicinal 
herb, purity of the composition and safety and efficacy of the final drug. However, 
quality standardization of MADPs suffers a lot of challenges as:
• Firstly, unlike allopathic drugs that are composed of a single or a fixed number 
of chemical compounds that are easy to be standardized, plants have a diverse 
range of phytoconstituents contributing to their bioactivity and it is very 
 difficult to isolate, purify and standardize that bioactive compound.
• Secondly, bioactivity is not constant but varies according to time (day, season, 
constellar position) and to region (arid, marshy).
• Thirdly, there are also differences in the bioactivity exists depending on the 
way a plant has been collected, processed and stored [16].
There are many more factors that contribute to the varied behavior of plant 
based drugs besides the ones stated above. Phytoconstituents that are responsible 
for the specific medicinal properties of a plant are not present in uniform quality 
or quantity under different edaphic (soil) conditions. The medicinal and toxic 
property of a plant may also vary according to the kind of processing through which 
it had undergone. Traditional, ancient systems of medicine used to take care of all 
these parameters and thus it had specific recommendations and procedures as to 
how a plant should be collected and processed in order to get its optimum efficacy.
Currently, there are modern analytical techniques like chromatography, spec-
troscopy and bioassay methods that can be used to determine the chemical profile 
of the selected medicinal plants and can compare their bioactivity and efficacy in 
treating one or the other disease [16].
Note: Information in the above paragraph has been taken from the country stud-
ies prepared for the Workshop on Medicinal Plants held in Bangalore, India, 22–26 
July 2004.
4. Constraints to the development of trade
While developing countries like India has huge potential in the marketing and 
trade of herbal drugs owing to their ancient knowledge and experience with the 
Ayurveda but they face a number of challenges and limitations that need to be 
addressed to meet the growing demands in the developed country markets [16].
a. Quality assurance: the herbal drugs need to be consistent in quality and 
should be free from contaminants. Unwanted ingredients like dirt, soil parti-
cles, plant parts, or any other chemical adulterant need to be addressed before 
final packaging and trade of the herbal product.
b. Consistent volume: the herbal drugs that are high in demand must be available 
in consistent volume so that there should be no pressure on natural resources 
and no exploitation of biodiversity occurs.
c. Strict regulatory laws: to regulate the collection, processing, storage, manu-
facturing and trade in herbal products, there should be strict norms laid by the 
concerned authority at local, national and international level.
d. Pre- and post-harvesting practises: the herbal plants that are harvested 
for the use in different products need to be monitored and their pre- and 
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post-harvesting practices must be standardized so that a consistent quality can 
be met. Also, as we discussed earlier, quality and quantity of bioactive compo-
nents are impacted depending upon pre- and post-harvesting practices.
e. Lack of proper knowledge: lack of proper knowledge in the species and variety 
of the plants many a times create confusion. There is limited knowledge of 
the herbs’ medicinal properties beyond traditional knowledge and belief. This 
restricts the use and marketability of the plants. Common man/consumers are 
unaware of these scientific terms and blindly trust the manufacturer or brand in 
this regard.
f. Lack of database/data repository: there must be a herbal drug repository and 
related database of all the medicinal plants found in the country, their avail-
ability, flowering season, abundance, medicinal properties, toxicity, etc. so that 
exploitation of natural resources can be stopped and endangered species of 
plants can be protected.
g. Lack of access to latest technology: developing countries/Poor countries often 
lack in accessing latest technologies for the quality assessment of the herbal 
drugs which results in compromising with the quality and efficacy of the drugs.
h. Research and development: often developing countries use a very less propor-
tion of their Gross Domestic Product (GDP) in research and development. In 
case of herbal drugs, research and development is the foremost requirement 
as the drugs are sourced from natural product and the environment in which 
these plants grow is ever changing with lot of mutations occurring resulting in 
change of bioactivity of phytoconstituents.
i. Intellectual property rights (IPR): plants cannot be protected under IPR as 
they have been used in traditional medicines for centuries. Any new discovery 
with a herbal drug that show its effectiveness in treating certain ailment can 
be patented. A therapy which is new for one region can be a part of regular 
practice for the other region of the world. Thus, everything cannot be pat-
ented. The plants can only be registered based on their availability in one or 
the other region and their status in the wild. Also, there is very little knowledge 
of the whole IPR field in the developing countries and the access to it is still 
lower. These issues are currently under discussion, debate and negotiation on a 
broader scale in the World Trade Organization (WTO).
j. Deliberate malpractices: beside lack of knowledge, there is sometimes 
deliberate adulteration and substitution in herbal drugs to make more money. 
Always the end users pay a cost of these malpractices and sometimes suffer due 
to inferior quality of the products which many a times produce side-effects.
A detailed review on the various malpractices in herbal drugs is discussed below.
4.1 Types of illegal/malpractices
Deliberate malpractices can be broadly classified into two categories-  
adulteration and substitution. The term ‘adulteration’ can be defined as 
‘admixturing or substituting original or genuine drug with inferior, defective 
or otherwise useless or harmful substance’. Adulteration in simple words is 
the debasement of an article [19]. The drugs may be adulterated with sub-




with artificially manufactured substance or with same exhausted drug or with 
synthetic chemicals to enhance natural character or with any other harmful 
adulterant. The drugs which are in powdered form are frequently adulterated 
as identification of adulterant becomes very difficult in powdered form of 
drugs. According to World Health Organization’s (WHO) publication on qual-
ity standards for medicinal plant materials, any batch of raw herbal drug which 
has more than 5% of any other plant part, even of the same plant say, stem in 
leaf drugs, should be strictly rejected never the less if they are derived from the 
authentic plant.
Substitution may be defined as a process of replacing partially or completely an 
authentic herbal drug with its different species or with different plant part or with 
any other material that have similar morphology or functional property so that the 
substitution may be difficult to detect.
4.1.1 Types of adulteration and substitution
a. Adulteration with inferior commercial varieties [20, 21]: they are added due to 
similarity in morphology; for example, black pepper (Piper nigrum) adulter-
ated by papaya seeds.
b. Adulteration by artificially manufactured substitutes [20, 21]: the artificially 
manufactured substance resembles the original drug. This method is used for 
the costlier drugs. For example, artificial invert sugar or cane sugar is added 
to Honey.
c. Adulteration by exhausted drugs [20, 21]: when the drug is devoid of medicinally 
active substance as it has been extracted already and then is used to make the 
herbal product, such substitution comes under this category. Mainly volatile oil 
containing drugs like clove, coriander, fennel, caraway are adulterated by this 
method. As it is devoid of colour and taste due to extraction, natural colour and 
taste is balanced with additives and synthetic chemicals, e.g. Clove, Fennel, etc.
d. Adulteration by addition of heavy metals [20, 21]: many a times due to non-
standardized or sub-standardized processing of raw herbal drugs, many harm-
ful pollutants from the soil and environment get added to the final product, 
e.g. pieces of limestone in asafoetida, lead in pieces of opium.
e. Adulteration by synthetic principles [20, 21]: synthetic chemicals are used to 
enhance natural colour, fragrance and taste of the exhausted drugs, e.g. adding 
Citral to oil of lime and orange.
f. Adulteration of powders [20, 21]: the drugs which are in the form of powders 
are frequently adulterated as it is almost impossible to detect the adulteration 
without any technological tool. For example, dextrin is added in ipecacuanha, 
exhausted ginger in ginger, red sanders wood in capsicum powder and pow-
dered bark adulterated with brick powder, metanil yellow in turmeric powder, 
chalk powder in wheat flour, red brick powder in red chili powder, chicory 
powder in coffee powder, etc.
g. Presence of vegetative matter of same plant [20, 21]: small pieces of all dried 
root, stem and leaf of different plant look similar. Some miniature plants 
growing along with the medicinal plants are added due to their colour, 
odour, and constituents. Small twigs, stems, leaves are often added to the 
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crude dried drug which cannot be differentiated by naked eye. For example, 
Mixture of crude Dashmoola drugs is often adulterated with some random 
twig, leaf and bark.
4.1.2 Reasons for adulteration and substitution
a. Non-availability of the authentic drug [20, 21]: due to over exploitation and 
unregulated deforestation, there has been shortage of many medicinal floras 
which has resulted in the endangerment of the species. Some of the plants have 
been extinct also, e.g. substitution of Oroxylum indicum in Dashmoola drugs.
b. Uncertainty in the identity of the drug [20, 21]: the local collectors of the medici-
nal flora are not much educated and get confused with the identity of the 
drugs that look similar. Also, some of the plant species are debatable among 
Ayurveda practitioners for the authenticity and thus interchangeably used by 
different practitioners, e.g. for the herb Lakshmana different species such as 
Arlia quinquefolia, Ipomea sepiaria, etc. are considered.
c. Cost of the drug [20, 21]: due to lesser prevalence of many medicinal floras, the 
cost of their respective drug rise. Manufacturers adulterate such drugs to make 
more money, e.g. saffron, asafoetida, etc.
d. Geographical distribution of the drug [20, 21]: many of the drugs that are found 
in one part of the country are not found in the other. This has resulted in sub-
stitution of such drugs with functionally similar drugs. For example, as Rasna, 
Plucia lanceolata is used in Northern India while in southeren parts Alpinia 
galanga is considered as the source.
e. The adverse reaction of the drug [20, 21]: different drugs have their varied impact 
on people depending upon their age, gender, physical condition, disorder, etc. 
Some of the drugs that show medicinal benefits in one person may show toxic 
effects in another. For example, Vasa is a well-known Rakta-Pittahara drug, but 
due to its Abortifacient activity its utility in pregnant women is limited, instead 
drugs such as Laksha, Ashoka, etc. are substituted.
f. Confusion in vernacular names [20, 21]: different species having similar vernac-
ular names and vice a versa an cause confusion that may result in adulteration. 
In Ayurveda, ‘Parpatta’ is a plant that refers to Fumaria parvifloran originally 
and in Siddha, ‘Parpadagam’ is another plant that refers to Mollugo pentaphylla. 
But due to similarity in the names in traditional systems of medicine, these two 
herbs are often interchanged or adulterated or substituted [19].
g. Lack of knowledge about original or authentic source [20, 21]: an example of 
such type of adulteration can be Mesua ferrea commonly known as Nagakesar. 
Market samples of Nagkesar is adulterated with flowers of Calophyllum inophyl-
lum because the suppliers are not aware about the abundance of authentic drug 
Mesua ferrea in the Western Ghats region and the parts of Himalayas. There 
may be some restriction s in the collection of drug from the protected forests 
too [19].
h. Similarity in morphology [20, 21]: owing to the similarity in morphological 
characteristics within the same genus, often the species are interchangeably 




having similarity in morphology. M. utilis (sold as white variety) and M. 
deeringiana (sold as bigger variety) are popular adulterants.
i. Similarity in colour or dye [20, 21]: colour can be a major reason of adulteration. 
Not all spices and drugs that give a peculiar colour to food or medicine source 
from original herb but can be adulterated with synthetic dyes. ‘Ratanjot’, origi-
nally derived from Ventilago madraspatana and collected from Western Ghats 
which is known to be the only source of red dye (ratanjot), is now derived from 
Arnebia euchroma var. euchroma. Though there is only similarity in the colour 
of the dye but still, whatever is available in the market, in the name of Ratanjot 
is originated from Arnebia euchroma [19].
j. Careless collections [20, 21]: some of the herbal adulterations are due to the care-
lessness of herbal collectors and suppliers. The collectors are local people who 
are not much educated and trained in proper collection guidelines. This results 
in degradation of many of the useful properties of the plant. Parmelia perlata is 
used in Ayurveda, Unani and Siddha. It is also used as grocery. Market samples 
showed it to be admixed with other species (P. perforata and P. cirrhata).
5.  Laws related to collection, harvest, processing and trade in medicinal 
Flora
As discussed earlier, with the growing interest in medicinal plants and ayurvedic 
drugs, there is a need for a long term strategy and planning to conserve and sustain-
able use of these plants [22–26]. Many medicinal plants like other natural resources 
are facing extinction and their degradation has accelerated over the years due to 
many reasons. Medicinal plants also face habitat destruction due to over exploita-
tion. Though Forest Conservation Act, 1980 and the Wildlife Protection Act, 
1972 provide some protection to medicinal plants. But as there are many medicinal 
floras that grow away from the domain of protected areas and there is no well-
planned strategy for their conservation, many of such unchecked floras face endan-
germent and become extinct. Even the floras within protected areas face depletion 
without proper conservation strategy. Beside this, indiscriminate and unregulated 
exploitation of medicinal plants for their roots, stem, bark, fruit, leaves, or whole 
plant leads to destructive harvesting which include 70% of the wild flora out of 
95%t used [16]. If not carefully monitored, this practice could lead to the depletion 
of genetic stocks and ultimately to the diversity of medicinal flora.
Though, government is making efforts to manage and regulate the collection of 
wild flora, but a long term strategy is needed. The efforts are scattered and do not yield 
satisfactory results. These efforts along with the well-planned strategies and policies 
are needed with major involvement of local communities and indigenous habitants.
Both in-situ and ex-situ conservation strategies need to be undertaken. In-situ 
conservation involves protecting bioreserves and biodiversity hotspots, e.g. The 
Himalayas, Sunderbans, Eastern and Western Ghats. Such biodiversity hotspots are 
rich in medicinal floras, thus protection of the indigenous plant species along with 
collection of raw drugs need to be regulated for sustainable development of natural 
resources. Ex-situ conservation involves setting up of gene banks, herbal botanical 
gardens, seed banks, drug repositories, nurseries, etc. so that the endangered spe-
cies can be raised again. The Department of Biotechnology, Government of India 
is working in this line and has taken various initiatives to establish gene banks.
In this regard, loss of traditional knowledge is always felt. Indigenous communi-
ties have a culture of worshipping sacred groves which is rich in plant diversity. 
Forensic Analysis - Scientific and Medical Techniques and Evidence under the Microscope
10
They know the ideal growth conditions and micro niches needed for these species to 
thrive. Even, tribal communities cultivate many medicinal plants for their personal 
use. For the large scale cultivation of such plants, there is a lot to learn from these 
communities. Thus, it becomes extremely important to involve tribal people, indig-
enous habitants in conservation programmes and to document their ethnobotanical 
knowledge to keep this living tradition alive.
In India, mainly three Acts cover medicinal plant issues at present. They are 
the Indian Forest Act, 1927, the Forest Conservation Act, 1980 and the Wildlife 
Protection Act, 1972. These acts do not cover much under their domain with respect 
to import, export, cultivation and trade related issues. Also, they focus on plant 
and animal resources as a whole but there is no separate law in our country that 
focuses on the conservation of medicinal flora in particular. The export and import 
of medicinal flora in India is governed according to Convention on International 
Trade in Endangered Species of Wild Fauna and Flora, 1975 commonly known as 
CITES. Being an international law CITES does not cover a vast flora which is country 
specific. Beside CITES, International Union for the Conservation of Nature and 
Natural Resources (IUCN) is another international organization that works in the 
field of nature conservation and sustainable use of natural resources. It is involved 
in data gathering and analysis, research, field projects, advocacy and education. 
In India, the Drugs and Cosmetics Rules, 1940 defines ASU drugs; regulate their 
trade, misbranding, adulteration or substitution and spurious drugs use in any 
Herbal or Polyherbal ASU formulation. Often, local vendors and manufacturers 
escape such laws to promote their brand and make profit.
Unregulated harvesting of medicinal plants always takes place outside the pro-
tected areas. All over the world, the species of medicinal floras that are banned for 
export are due to their endangered status in the wild and not because of the medicinal 
value they hold. There is a need of urgent national level policy for the consolidated 
effort towards the conservation of medicinal plants. Policies must be formulated 
keeping in mind the various user groups of medicinal plants. It should advocate in-
situ and ex-situ conservation both. The policy should review all existing institutions 
working in this domain and also build new ones. Most importantly, the policy needs 
to take into account the legal and regulatory mechanisms related to medicinal plants.
Several efforts are afoot towards the formulation of such policies but we have yet 
to see something more concrete in this direction.
6. Forensic implications of herbal drugs
A simple understanding about forensics is that anything which is illegal and 
unregulated by the laws, directly or indirectly tends to harm individuals automati-
cally comes under the purview of Forensic Science.
With the growing trend in medical tourism, most of the western countries have 
travelers that travel in Asian and East Asian countries for the purpose of taking natural 
treatment and remedies. Such wellness centres offers a variety of herbal medications 
for the sale. Patients visiting such centres wrongly believe that they are being treated 
by natural therapy without getting any harmful chemicals and drugs administered 
in their body. But how much regulated such centres and their medications are, pose a 
serious concern. There have been a number of studies that show the adulteration and 
the substitution in herbal drugs as it is not much regulated by the Pharmacopeia as 
compared to the allopathic medicines that have strict chemical compositions and are 
registered under the Drug and Cosmetic Acts of different countries [27, 28].
The second most alarming concern about the consumption of adulterated 




preparations can have anything ranging from heavy metals to pesticides in them 
that may show antagonistic effects upon interacting with chemical drugs con-
sumed by the patient. Usually patients do not share their history of consumption 
of herbal drugs as they think it to be natural and posing no side-effects and also 
there is no such prescription associated with such herbal supplements. The online 
websites are flooded with such nutraceuticals, dietary supplements and other 
herbal powder that claim relief and other health associated benefits but neither 
such companies nor such herbal supplements are often registered under any 
government regulating agency [29].
Third serious issue is the addition of prescription drugs in the herbal supple-
ments to enhance their efficacy, as this may cause serious issues in the person 
having allergies to certain compounds. The most common example of such adul-
terations is the addition of steroidal drugs. Such medications can be contraindicated 
in a person consuming non-steroidal, anti-inflammatory agents [30].
Fourthly, there is sometimes very high and potentially lethal concentra-
tions of metals are present in these unregulated herbal drugs. When there is an 
unexpected death occurs, the investigating officers rigorously document all the 
medications, prescriptions taken by the deceased and found at the crime scene 
as the medico-legal experts believe the cause of death to the overdose of such 
prescriptions but unfortunately this is not the case with the natural herbal medi-
cines. Also, there is near to impossible chances of detection of such medicines 
during autopsy as these medicines are generally consumed by the patient over the 
long period of time [30].
There have been reports of Lead encephalopathy and acute lead and mercury 
poisoning in patients consuming herbal drugs. Roger W. Byard in his publication on 
‘Potential Forensic Significance of Traditional Herbal Medicines’ gave examples of 
such toxicity in which ‘a 5- year old boy who had been treated with ‘Tibetan Herbal 
vitamins’ and had ingested a total of approximately 63 g of lead over 4 years. He has 
given another example of a case of a 5-year-old boy with bilateral retinoblastoma 
whose parents relied on to a traditional remedy that caused him arsenic poisoning.’ 
The issues quoted in the above two cases can be summarized as ‘non-medically 
qualified healers, lack of product standards, undeclared ingredients, nondisclosure 
of usage and long-term medication’ [29].
7. What can be done: a way forward
In the light of the above stated issues, there are a number of measures that can be 
taken at the country as well as local level for improving the Herbal drug sector and 
enhancing the development of a more effective trade in medicinal plants and their 
products in developing countries [16].
a. Improvement of land resources: in order to guarantee an uninterrupted sup-
ply of raw drug, there must be provisions for organized and protected cultiva-
ble land that ensures regular supply.
b. Reduction in intermediaries: there are a number of middlemen and interme-
diaries involved in the market chain of herbal medicines that are needed to be 
reduced to avoid malfunctions and enhance the profit of primary beneficiaries 
like farmers and cultivators.
c. Research and development: trade and development in any country can grow 
with more and more investment of GDP in research and development. Research 
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and development on selected species, their active constituents, processing and 
preservation is highly needed in developing countries like India. Not only this, 
but R&D has a major role to play in identification and detection of adulteration 
in traded herbal products. Thus this area needs a lot of development.
d. Legal provisions: for a healthy competition in market, high quality supply of 
planting materials, quality control systems, improved cultivation and encour-
agement of investments in new technologies, there should be strict laws and 
regulatory provisions that guides in these areas.
e. Value addition: through processing, and improved marketing of the medici-
nal plants, value should be added to this industry so that the benefits of the 
expanded interest in medicinal plants be more equitably shared.
f. Development of market chain: a holistic approach needs to be adopted for the 
promotion of trade. Specific interventions which only target the collectors are 
insufficient. The organic nature of the produce should be explored and capital-
ized on for export marketing.
g. Post-collection handling: improvements are needed in the areas of post-
collection handling, value addition and product presentation.
h. Sustainable development: developing countries like India should aim to culti-
vate their resources in a sustainable manner so that judicious use of resources is 
ensured.
i. In-depth approach: a more in-depth approach should be undertaken to 
clarify market issues, and consider more effective solutions. Case studies of 
successful marketing approaches being used may assist other organizations 
or countries. Products which would be most amenable to sustainable com-
mercial development and industrial processing in the supplying countries 
must be identified.
j. Awareness and knowledge: there should be awareness programmes conducted 
at intervals for the consumers to educate them about what they consume, how 
they can decide which product is good for their health, how they can detect in a 
simple way about the authenticity of herbal drugs while purchasing.
k. Standardization and quality assurance: regulating agencies must codify 
certain standards and parameters that must be fulfilled by the product in order 
to be sold in the market and the ones that do not qualify those standards should 
be eliminated at once.
l. Forensic aid: whenever any illegal trade, import or export of herbal drugs 
comes in knowledge of the officials, there is no separate wing of government 
that tackle such issues. Every country must recognize the need of Forensic 
intervention in cases of Herbal drugs. There should be well-defined labora-
tories under forensic department that can analyze the trafficked herbal drug, 
authenticate it, trace its source and find adulterants and substitutes present in 
it. Not only trafficked drugs but the drugs from the local market should also be 
taken into account. Fraud is always a crime whether it is related to accounts/
documents/funds which causes monetary loss or related to products sold in the 





Unlike conventional Allopathic and Homeopathic drugs that are usually prepared 
from synthetic, chemically pure materials by means of reproducible manufacturing 
techniques and procedures, ASU drugs may vary in composition and properties a 
lot [31]. Thus, in case of ASU drugs also, it is a prerequisite to ensure the reproduc-
ibility of batches of medicines by its correct identification and quality assurance so 
that its safety and efficacy can be maintained [32, 33]. Adulteration, substitution, 
counterfeiting and usage of inferior quality of drugs often result in degradation of 
clinical effects of ASU drugs. This makes authentication a crucial step in successful 
and reliable applications. In cases where there is availability of similar looking drugs 
or drugs of same chemical nature, authentication becomes more crucial to avoid even 
any chance adulteration with other varieties of drug. Using a wrong drug may result 
in worsening the condition or may act as antagonist [34]. Evaluation has become 
even more difficult when several different individual species were powdered and 
mixed together in a proprietary medicine [35]. It is also important to take care of each 
step of harvest, storage, processing and formulation because it has a huge impact on 
the final quality of the product. Thus, to ensure the optimal safety and efficacy of 
these products, quality assurance in manufacturing and storage is a must. Also, these 
control measures are critical for the pharmacological and toxicological evaluation of 
the ASU drugs. Authentication of ASU drugs involve following techniques:
8.1 Taxonomic identification
In this method, the plant at its source is determined based on its scientific 
binomial nomenclature, i.e. genus and species determination. This gives the 
information about the botanical origin of the plant. Before designating the plant to 
its taxonomic class, its binomial name, vernacular names, site of collection of plant 
material, details of collector, habitat, season of collection, flowering, altitude and 
part collected, etc. are required [36].
8.2 Herbarium voucher sample
The sample of collected material should be authenticated by an expert in the 
field and kept as a voucher sample in a herbarium or a research institute for future 
references [36].
8.3 Macroscopic method
Macroscopic examination of botanical materials involve examination of certain 
macroscopic properties also known as organoleptic properties like shape, size, colour, 
texture, surface characteristics, fracture characteristics, odour, taste, etc. [37].
8.4 Microscopic method
Microscopy is a technique that is used to determine the structural, cellular and 
internal tissue features of plant material. It helps in identification and differen-
tiation between two herbals that are similar in morphology [38, 39]. This is the com-
monly used technique, convenient, quick and non-destructive [40]. Microscopy 
involves varied techniques like compound, bright field, dark field, fluorescence 
and electron microscopy (Scanning Electron Microscopy known as SEM and 
Transmission Electron Microscopy known as TEM) that offer different features 
based upon the requirement.
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8.5 Physicochemical methods
Physicochemical parameters include moisture content, total ash content, water 
soluble ash, acid insoluble ash and sulphated ash. These values of the individual 
drugs can be compared with the standard values of Indian pharmacopeia and thus 
their identity can be ascertained [41].
8.6 Spectral methods
Spectral methods like infrared (IR) spectroscopy and ultraviolet- visible (UV–Vis) 
spectroscopic methods are extremely helpful structural elucidation of active con-
stituents derived from botanical material. Not only structural elucidation but also 
its fingerprinting can be done by these techniques. They offer comparison between 
the natural and the synthetic compounds. Also, both qualitative and quantitative 
analysis can be done. Such techniques when integrated with chemometric tools like 
Principal Component Analysis (PCA) that help in handling multivariate data without 
prior knowledge about the study samples, becomes a boon [42, 43]. As chemometric 
analysis of spectral data does not require any chemical treatment, the method offers a 
rapid and simple analysis [44].
8.7 Chromatographic methods
High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis 
(CE) and Thin Layer Chromatography (TLC) are the most commonly used analytical 
techniques for the profiling of herbal products [45]. Beside these, gas chromatography 
(GC) can be used for the analysis of volatile components in herbal medicines [46].
8.7.1 Thin layer chromatography (TLC)
TLC is the earliest of chromatographic methods employed for the separation of 
plant constituents. As the herbal extract is a combination of hundreds of components 
that are responsible for its activity, it is very important to separate those components 
and study each of them individually. TLC provides first characteristic fingerprints of 
herbs. The main advantages of using TLC to develop the fingerprint or chemical pro-
file of herbal medicines are its simplicity, versatility, high velocity, specific sensitivity, 
simple sample preparation and its economy. Thus TLC is a convenient method to 
determine the quality and possible adulteration of herbal products [47].
8.7.2 High performance liquid chromatography (HPLC)
After TLC, HPLC has become the most popular method for the analysis of 
herbal medicines. Though it is more complex than TLC, but still easier to learn and 
use and is not limited by the volatility or stability of the sample compound as is the 
case with GC. In general HPLC can be used to analyze almost all the compounds in 
herbal medicines [48]. HPLC can be linked to various detectors like UV detector, 
Refractive index detector and Mass Spectrometric (MS) detector that can help in 
knowing the exact chemical makeup of the components.
8.7.3 Gas chromatography (GC)
Volatile oils and other thermally unstable components that cannot be detected 
by HPLC technique can be detected by GC. The extraction of the volatile com-




be readily identified using GC–MS analysis. The advantages of GC lie in its high 
sensitivity of detection for almost all the volatile chemical compounds [46].
8.8 Chemical fingerprinting
A chemical fingerprinting is a unique pattern just like human fingerprints which 
is unique for every individual, which indicates the multiple chemical markers within 
a sample [49]. The European Medicines Agency (EMEA) defines chemical markers 
as chemically defined constituents, or group of constituents of herbal medicinal 
product which are of interest, regardless whether they possess any therapeutic 
activity [50]. Such chemical markers are critical in identification and authentica-
tion of the plants from which they are derived. The quantity of a chemical marker 
is proportional to the quality of herbal medicine. The study of chemical markers 
is applicable to many research areas, including authentication of genuine species, 
search for new resources or substitutes of raw materials, optimization of extraction 
and purification methods, structure elucidation and purity determination.
8.9 Molecular markers
Molecular markers are the constituents that include primary and secondary 
metabolites and other macromolecules like nucleic acids. DNA as a marker can 
be a reliable instrument as it is in cases of disputed identity of human beings, in 
establishing the genetic makeup and polymorphisms of each species [51]. The 
main advantage associated with DNA is that, it can be extracted from both fresh 
and dried organic tissue of the botanical material and thus is not restricted by the 
physiological nature of the sample to be assessed [52, 53]. Various types of DNA 
based molecular techniques such as hybridization based methods, polymerase chain 
reaction (PCR) based methods and sequencing based methods are utilized to evalu-
ate DNA polymorphisms [54–56].
9. Conclusion
This chapter has provided an overview of trends and conditions relating to 
medicinal plants, their production, markets and malpractices. It is never possible 
to include each and every detail, data and analysis related to medicinal plants in 
a single chapter. Thus, the chapter is initial effort to increase awareness of both 
the potentials and problems associated with medicinal plants and its industry. 
Substitution of herbs can never be eliminated as with more and more dependence 
on ASU drugs, more than 300 medicinal plants have become red listed. So, in order 
to achieve constant supply of botanical drugs, experts must find suitable substitute 
in a regulated manner. Substitution in a well-defined manner may provide a greater 
scope for the physicians to utilize herbs that are easily available, cost effective and 
most appropriate for the clinical condition. The need of substitution should always 
be separated with the intention to substitute and adulterate in order to make more 
profits. Not all adulterations are intentional. Sometimes it is the lack of awareness 
of the suppliers about the spurious materials, their toxic effects, confusion in name, 
non-availability and lack of knowledge about authentic plant may also result in 
adulteration and substitution. WHO, in its publication on quality standards for 
medicinal plant materials, recommends rejecting any batch of raw material, which 
has more than 5% of any other plant part of the same plant (e.g. stem in leaf drugs), 
never the less if they are derived from the authentic plant. Based on these standards, 
adulteration whether, intentional or unintentional, should be rejected. In order to 




1 School of Forensic Science (School of Doctoral Studies and Research), National 
Forensic Sciences University, Gandhinagar, Gujarat, India
2 School of Forensic Science, National Forensic Sciences University, 
Gandhinagar, Gujarat, India
*Address all correspondence to: astha.pandey@gfsu.edu.in
detect such adulterations, technologies have a crucial role to play. The detection of 
chemical markers is always a good choice in such cases. According to EMEA these 
chemical markers have nothing to do with the therapeutic activity of the drug; 
they help in chemical fingerprinting of the botanicals to authenticate its source. 
Nowadays, Ayurvedic drug industries follow high quality standards using modern 
techniques and instruments to maintain their quality. Thus, suppliers and traders 
should also be educated about these parameters to avoid any chance adulteration. 
Beside all these, there should be strict regulatory laws to govern the quality stan-
dards and trade in medicinal flora. Whenever there is any fraud or illegal practice, 
Forensic Science has always a role to play. Herbal drugs forensic is that only branch 
of Forensic Science that deals with all such issues.
‘We can’t talk about our own health without understanding our place in our 
environment, because in order to fulfil our potential we have to live in the context 
of our surroundings. We have to know our place in the ecosystem of which we are a 
part, and this means living 'consciously': being aware of nature and how it affects us 
and how we, in turn, affect nature’.
A quote from Sebastian Pole’s ‘Discovering the True You with Ayurveda: How to 
Nourish, Rejuvenate, and Transform Your Life’, very well explains the importance 
of awareness, be it our surrounding, our body, our food or our medicine. Therefore, 
Herbal drug forensics is one of the most significant emerging fields of forensic science.
Acknowledgements
The authors extend their sincere gratitude to National Forensic Sciences 
University and Dravyagun department, Banaras Hindu University for their constant 
support and all the resources they provided.
Conflict of interests
The authors declare no conflict of interests.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 




[1] Laursen M. Ayurveda: A Brief 
History of an Ancient Healing Science 
[Internet]. 1 July 2017. California, USA: 




[Accessed: 10 November 2020]
[2] Essential Medicines and Health 
Products Information Portal: A World 
Health Organization resource [Internet]. 
2015. Available from: http://apps.who.
int/medicinedocs/en/d/Jh2943e/8.4.html 
[Accessed: 10 November 2020]
[3] Introduction to Ayurveda: Banyan 





[4] Vasant L. The Ayurvedic Institute 








pW [Accessed: 10 November 2020]
[5] Agrawal S, Pandey A. Boosting 
India’s immunity through Ayurveda 
against Covid-19. Acta Scientific 
Pharmacology. 2020;1(8):28-32
[6] Coyle HM, editor. Forensic Botany: 
Principles and Applications to Criminal 
Casework. 1st ed. Florida: CRC 
Press; 2004
[7] Margiotta G, Bacaro G, Carnevali E, 
Severini S, Bacci M, Gabbrielli M. 
Forensic botany as a useful tool in the 
crime scene: Report of a case. Journal of 
Forensic and Legal Medicine. 2015;34: 
24-28
[8] Tewari NN. Some crude drugs: 
Source, substitute and adulterant with 
special reference to KTM crude drug 
market. Sachitra Ayurveda. 1991;44(4): 
284-290
[9] Vasudevan NK, Yoganarasimhan KR, 
Murthy K, Shantha TR. Studies on some 
south Indian market samples of 
Ayurvedic drugs. Ancient Science of 
Life. 1983;3(2):60-66
[10] Bisset WG. Herbal Drugs and 
Phytopharmaceuticals. London: CRC 
Press; 1984
[11] Saraswathy A. Adulterants and 
substitutes in Ayurveda. Sachitra 
Ayurved. 2001;54(1):63-66
[12] Gupta AK. Quality Standards of 
Indian Medicinal Plants. Vol. 1. New 
Delhi: ICMR; 2003
[13] De Smet PAGM, Keller K, Hansel R, 
Chandler RF. Adverse Effects of Herbal 
Drugs. Vol. 1. Heidelberg: Springer 
Verlag; 1992
[14] Agrawal S, Pandey A. Herbal drugs 
forensics. International Journal of 
AYUSH. 2020;9(2):75-81
[15] National Medicinal Plant Board: 
Introduction. 2015. Available from: 
https://www.nmpb.nic.in/ [Accessed: 
12 November 2020]
[16] Trade in Medicinal Plants, Raw 
Materials, Tropical and Horticultural 
Products Service Commodities and 
Trade Division Economic and Social 
Department Food and Agriculture 
Organization of the United Nations 
Rome. 2005. Available from: http://
www.fao.org/3/af285e/af285e00.pdf 
[Accessed: 12 November 2020]
[17] De Silva T. Industrial utilisation of 
medicinal plants in developing 
References
Forensic Analysis - Scientific and Medical Techniques and Evidence under the Microscope
18
countries: Medicinal plants for forest 
conservation and healthcare. In: Non-
Wood Forest Products 11. Rome: Food 
and Agriculture Organization of the 
United Nations; 1997. p. 34
[18] Titz A. Medicinal Herbs and Plants—
Scope for Diversified and Sustainable 
Extraction. Bangalore, India; 2004
[19] Kumar KR, Rohit KS, Gajana P, 
Abdulah, Singh JP, Srinivasulu B. A 
comprehensive review on adulteration 
of raw materials used in Asu drug 
manufacturing. International Journal of 
Ayurveda and Pharma Research. 
2018;6(3):66-71
[20] Prakash O, Jyoti KA, Kumar P, 
Manna NK. Adulteration and 
substitution in Indian medicinal plants: 
An overview. Journal of Medicinal 
Plants Studies. 2013;1(4):127-132
[21] Poornima B. Adulteration and 
substitution in herbal drugs a critical 
analysis. International Journal of 
Research Ayurveda and Pharmacy. 
2010;1(1):8-12
[22] Foundation for the Revitalisation of 
Local Health Traditions. Conserving a 
National Resource. Need for a National 
Programme on Medicinal Plants 
Conservation Draft of Madras 
Consultation 1997 (unpublished)
[23] Farmsworth NR, Soejarto DD. 
Global Importance of Medicinal Plants. 
Cambridge: Cambridge University 
Press; 1991
[24] Jha AK. Medicinal plants: Poor 
regulation blocks conservation. Economic 
and Political Weekly. 1996;270:3
[25] Srivastava J, Lambert J, 
Vietmeyer N. Medicinal Plants. A 
Growing Role in Development. 
Washington, DC: The World Bank; 1995
[26] Bhatt S. Why does India Need a 






the%20forest. [Accessed: 18 
November 2020]
[27] University of Adelaide. Deaths Due 
to Tainted Herbal Medicine Under-
Recorded. ScienceDaily; 2018. USA. 
Available from: www.sciencedaily.com/
releases/2018/10/181025103344.htm. 
[Accessed: 22 February 2021]
[28] Farringtona R, Musgravea I, 
Nashb C, Byarda RW. Potential  
forensic issues in overseas travellers 
exposed to local herbal products. 
Journal of Forensic and Legal Medicine. 
2018;60:1-2
[29] Byard RW. A review of the potential 
forensic significance of traditional 
herbal medicines. Forensic Science. 
2010;55(1):89-92. DOI: 10.1111/j.1556-
4029.2009.01252.x. Available from: 
interscience.wiley.com
[30] Byard RW, Musgrave I. Herbal 
medicines and forensic investigations. 
Forensic Science, Medicine, and 
Pathology. 2010;6:81-82. DOI: 10.1007/
s12024-010-9157-x
[31] Revathy SS, Rathinamala R, 
Murugesan M. Authentication methods 
for drugs used in Ayurveda, Siddha and 
Unani systems of medicine: An overview. 
International Journal of Pharmaceutical 
Sciences and Research. 2012;3(8): 
2352-2361
[32] Strans SE. Herbal medicines—
What’s in the bottle? The New England 
Journal of Medicine. 2002;347:1997-1998
[33] De Smet PAGM. Herbal remedies. 
The New England Journal of Medicine. 
2002;347:2046-2056
[34] Cosyns JP, Jadoul M, Squifflet JP, 




lesions in Chinese herb nephropathy. 
American Journal of Kidney Diseases. 
1999;33:1011-1017
[35] Zhao ZZ et al. Application of 
microscopy in authentication of Chinese 
latent medicine—Bo Ying compound. 
Microscopy Research and Technique. 
2005;67:305-311
[36] Smille TJ, Khan IA. A comprehensive 
approach to identifying and authenti-
cating botanical products. Clinical 
Pharmacology and Therapeutics. 2010; 
87(2):175-186
[37] WHO. Quality Control Methods for 
Medicinal Plant Materials. Geneva: 
WHO; 1998
[38] Cheng XX, Kang TG, Zhao ZZ. 
Studies on microscopic identifying of 
animal drugs remnant hair (3): 
Identification of several species of 
Cauda cervi. Journal of Natural 
Medicines. 2007;57:163-171
[39] Lau PW, Peng Y, Zhao ZZ. 
Microscopic identification of Chinese 
patent medicine—Wu Zi Yan Zong. 
Wang Journal of Natural Medicines. 
2004;58:258-265
[40] Pharmacopoeia Commission for 
Indian Medicine & Homoeopathy. The 
Ayurvedic Pharmacopoeia of India. Delhi 
(India): The Controller of Publications 
Civil lines, Ministry of Health and Family 
Welfare of India; 2001. p. 3.
[41] Pharmacopoeia Commission for 
Indian Medicine & Homoeopathy. 
Indian Pharmacopoeia. New Delhi, 
India: Controller of Publications; 
1995;2:A 54.
[42] Horborne JB. Phytochemical 
Methods, a Guide to Modern Techniques 
of Plant Analysis. 3rd ed. UK: Chapman 
and Hall; 1998
[43] Miller JN, Miller JC. Statistics and 
Chemometrics for Analytical Chemistry. 
4th ed. Prentice Hall; 2000
[44] Sim CO et al. Assessment of Herbal 
Medicines of Chemometrics—Assisted 
FTIR Spectra. Journal of Analytica 
Chimica Acta; 2004
[45] Baralcat HH, Sahar Hussin AM, 
Mohamed Marzouk S, Merfort I, 
Linscheid M, Nawwar Mohamed AM. 
Polyphenolic metabolities of Epilobium 
hirsutum. Phytochemistry. 
1997;46:935-941
[46] Liang Y-Z et al. Quality control  
of herbal medicines. Journal of 
Chromatography B. 2004;812:53-70
[47] Chau FT, Chan TP, Wang J. TLCQA: 
Quantitative study of thin layer 
chromatography. Journal of Bio-
informatics. 1998;14(6):540-541
[48] Lin G, Li P, Li SL, Chan SW. 
Chromatographic analysis of Fritillaria 
isosteroidal alkaloids, the active 
ingredients of Beimu, the antitussive 
traditional Chinese medicinal herb. 
Journal of Chromatography. A. 2001; 
935:321-338
[49] Li S et al. Chemical markers for the 
quality control of herbal medicine: An 
overview. Chinese Medicine. 2008;3:7
[50] The European Medicines Agency: 
Reflection Paper on Markers Used for 
Quantitative and Qualitative Analysis of 
Herbal Medicinal Products and 
Traditional Herbal Medicinal Products. 
2008. Available from: http://www.emea.
europa.eu/pdfs/human/hmpc/253 
62907en.pdf [Accessed: 20 
November 2020]
[51] Chan K. Some aspects of toxic 
contaminants in herbal medicines. 
Chemosphere. 2003;52:1361-1371
[52] Warude D, Chavan P, Kalpana J, 
Patwardhan B. DNA isolation from fresh 
and dry plant samples with highly acidic 
tissue extracts. Plant Molecular Biology 
Reporter. 2000;21:1
Forensic Analysis - Scientific and Medical Techniques and Evidence under the Microscope
20
[53] Singh M, Bandana, Ahuja PS. 
Isolation and PCR Amplification of 
Genomic DNA from Market Samples of 
Dry Tea. Plant Molecular Biology 
Reporter. 1999;17:171-178. Available 
from: https://doi.org/10.1023/ 
A:1007562802361
[54] Joshi SP, Ranjekar PK, Gupta VS. 
Molecular markers in plant genome 
analaysis. Current Science. 1999;77: 
230-240
[55] Powell W, Morganite M, Andre C, 
Hanafly M, Vogel J, Tingey S, et al. 
Molecular Breeding. 1996;2:225-238
[56] Botstein D, White RL, Skolnick M, 
Davis RW. Construction of a genetic 
linkage map in man using restriction 
fragment length polymorphisms. 
American Journal of Human Genetics. 
1980;32:314-331
